To diet or not to diet – that is still the question

Por Rieger, Johannes, Steinbach, Joachim P.
Publicado no Neuro Oncol (2016)

Tp53-induced Glycolysis and Apoptosis Regulator (TIGAR) Protects Glioma Cells from Starvation-induced Cell Death by Up-regulating Respiration and Improving Cellular Redox Homeostas...

Por Wanka, Christina, Steinbach, Joachim P., Rieger, Johannes
Publicado em 2012

Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma

Por Bähr, Oliver, Hattingen, Elke, Rieger, Johannes, Steinbach, Joachim P.
Publicado em 2011

Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors

Por Burger, Michael C., Zeiner, Pia S., Jahnke, Kolja, Wagner, Marlies, Mittelbronn, Michel, Steinbach, Joachim P.
Publicado no PLoS One (2016)

Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival

Por Hattingen, Elke, Jurcoane, Alina, Daneshvar, Keivan, Pilatus, Ulrich, Mittelbronn, Michel, Steinbach, Joachim P., Bähr, Oliver
Publicado em 2013

Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern

Por Burger, Michael C., Mildenberger, Iris C., Wagner, Marlies, Mittelbronn, Michel, Steinbach, Joachim P., Bähr, Oliver
Publicado no Int J Mol Sci (2017)

Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A (1)H-Magnetic Resonance Spectroscopy Study

Por Steidl, Eike, Pilatus, Ulrich, Hattingen, Elke, Steinbach, Joachim P., Zanella, Friedhelm, Ronellenfitsch, Michael W., Bähr, Oliver
Publicado no PLoS One (2016)

ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors

Por Bähr, Oliver, Gross, Stefanie, Harter, Patrick N., Kirches, Elmar, Mawrin, Christian, Steinbach, Joachim P., Mittelbronn, Michel
Publicado no Oncol Lett (2017)

Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a (31)P/(1)H MRSI and quantitative magnetic resonance imaging study

Por Hattingen, Elke, Jurcoane, Alina, Bähr, Oliver, Rieger, Johannes, Magerkurth, Jörg, Anti, Sandra, Steinbach, Joachim P., Pilatus, Ulrich
Publicado em 2011

Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases

Por Burger, Michael C., Wagner, Marlies, Franz, Kea, Harter, Patrick N., Bähr, Oliver, Steinbach, Joachim P., Senft, Christian
Publicado no J Clin Med (2018)

Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity a...

Por Genßler, Sabrina, Burger, Michael C., Zhang, Congcong, Oelsner, Sarah, Mildenberger, Iris, Wagner, Marlies, Steinbach, Joachim P., Wels, Winfried S.
Publicado no Oncoimmunology (2015)

Bevacizumab for Patients with Recurrent Multifocal Glioblastomas

Por Burger, Michael C., Breuer, Stella, Cieplik, Hans C., Harter, Patrick N., Franz, Kea, Bähr, Oliver, Steinbach, Joachim P.
Publicado no Int J Mol Sci (2017)

Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation

Por Heller, Sonja, Maurer, Gabriele D., Wanka, Christina, Hofmann, Ute, Luger, Anna-Luisa, Bruns, Ines, Steinbach, Joachim P., Rieger, Johannes
Publicado no Int J Mol Sci (2018)

Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy

Por Maurer, Gabriele D, Brucker, Daniel P, Bähr, Oliver, Harter, Patrick N, Hattingen, Elke, Walenta, Stefan, Mueller-Klieser, Wolfgang, Steinbach, Joachim P, Rieger, Johannes
Publicado em 2011

Comprehensive diagnostics in a case of hereditary diffuse leukodystrophy with spheroids

Por Meyer-Ohlendorf, Marie, Braczynski, Anne, Al-Qaisi, Omar, Gessler, Florian, Biskup, Saskia, Weise, Lutz, Steinbach, Joachim P., Wagner, Marlies, Mittelbronn, Michel, Bähr, Oliver
Publicado no BMC Neurol (2015)

Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma

Por Ronellenfitsch, Michael W., Zeiner, Pia S., Mittelbronn, Michel, Urban, Hans, Pietsch, Torsten, Reuter, Dirk, Senft, Christian, Steinbach, Joachim P., Westphal, Manfred, Harter, Patrick N.
Publicado no Acta Neuropathol Commun (2018)

Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermet...

Por Wick, Wolfgang, Steinbach, Joachim P., Platten, Michael, Hartmann, Christian, Wenz, Frederik, von Deimling, Andreas, Shei, Peipei, Moreau-Donnet, Valerie, Stoffregen, Clemens, Combs, Stephanie E.
Publicado em 2013

Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems

Por Luger, Anna-Luisa, Sauer, Benedikt, Lorenz, Nadja I., Engel, Anna L., Braun, Yannick, Voss, Martin, Harter, Patrick N., Steinbach, Joachim P., Ronellenfitsch, Michael W.
Publicado no Int J Mol Sci (2018)

ERGO: A pilot study of ketogenic diet in recurrent glioblastoma

Por RIEGER, JOHANNES, BÄHR, OLIVER, MAURER, GABRIELE D., HATTINGEN, ELKE, FRANZ, KEA, BRUCKER, DANIEL, WALENTA, STEFAN, KÄMMERER, ULRIKE, COY, JOHANNES F., WELLER, MICHAEL, STEINBACH, JOACHIM P.
Publicado em 2014

ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy

Por Zhang, Congcong, Burger, Michael, Schönfeld, Kurt, Genβler, Sabrina, Sahm, Christiane, Naundorf, Sonja, Odendahl, Marcus, Nowakowska, Paulina, Tonn, Torsten, Grez, Manuel, Steinbach, Joachim P, Wels, Winfried S
Publicado em 2013